Jiangsu Hengrui reported CNY36.12B in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Cspc Pharmaceutical 6.78B 1.6B Dec/2024
Kangmei Pharma CNY 894.14M 120.63M Mar/2025
Sh Fosun Pharma CNY 12.96B 757.22M Jun/2025
Sh Pharmaceutical CNY 39.09B 2.93B Jun/2025
Sino Biopharmaceutical CNY 3.38B 2.09B Dec/2024
Wuxi Apptec CNY 21.49B 3.37B Jun/2025
Zz Pientze Pharmaceu 1.39B 93.82M Mar/2025